Acadia Pharmaceuticals Inc SEC filings ACAD
Acadia Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Nov 9, 2010. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 23, 2025 | — |
| CORRESP | Letter to the SEC | May 21, 2025 | — |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| DEFR14A | Filing | May 13, 2022 | — |
| CT ORDER | Filing | May 4, 2022 | — |
| DEFR14A | Filing | May 12, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 2, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 5, 2021 | — |
| CT ORDER | Filing | May 6, 2020 | — |
| CT ORDER | Filing | Nov 20, 2019 | — |
| CT ORDER | Filing | Apr 26, 2019 | — |
| CT ORDER | Filing | Apr 9, 2019 | — |
| CT ORDER | Filing | Mar 21, 2019 | — |
| CT ORDER | Filing | Sep 20, 2018 | — |
| CT ORDER | Filing | Mar 19, 2018 | — |
| CT ORDER | Filing | Mar 19, 2018 | — |
| CT ORDER | Filing | Sep 12, 2017 | — |
| CT ORDER | Filing | Mar 24, 2017 | — |
| CT ORDER | Filing | Jan 4, 2017 | — |
| CT ORDER | Filing | Dec 22, 2016 | — |
| CT ORDER | Filing | Sep 23, 2016 | — |
| CT ORDER | Filing | May 19, 2016 | — |
| CT ORDER | Filing | Dec 23, 2015 | — |
| CT ORDER | Filing | Apr 20, 2015 | — |
| CT ORDER | Filing | Apr 20, 2015 | — |
| CT ORDER | Filing | Aug 22, 2013 | — |
| D | Filing | Jan 2, 2013 | — |
| EFFECT | Filing | Dec 28, 2012 | — |
| CT ORDER | Filing | Apr 23, 2012 | — |
| CT ORDER | Filing | Apr 2, 2012 | — |
| CT ORDER | Filing | Apr 2, 2012 | — |
| EFFECT | Filing | Jan 6, 2012 | — |
| CT ORDER | Filing | Jun 14, 2011 | — |
| D | Filing | Jan 24, 2011 | — |
| EFFECT | Filing | Jan 21, 2011 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACAD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1070494
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.